Evidence map›Paper›PMID 41735625›Full record

SynthesisJournal of robotic surgery2026

Comparative efficacy of nephron-sparing surgery versus total nephrectomy on operative and prognostic results in pT2 kidney tumors: a meta-analysis.

Xiao-Yu Zhou, Ling-Yan Gou, Jiao Qin, Si-Meng Gan, Jin-Yun Yin, Song Cao, Hong-Yuan Li, Hao-Tian Huang, Qian-Long Li, Xue-Song Yang

Abstract readMeta-AnalysisComparative Study
PubMed Publisher
In one paragraph

Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiao-Yu Zhou *Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Ling-Yan Gou *Surgical Center, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Jiao Qin *Department of anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Si-Meng GanWest China Hospital of Sichuan University, Chengdu, China.
Jin-Yun YinDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Song CaoDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Hong-Yuan LiDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Hao-Tian HuangDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Qian-Long LiHealth Management Center, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Xue-Song YangDepartment of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Xuesongyang2022@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare the impact of partial nephrectomy (PN) versus radical nephrectomy (RN) on perioperative and prognostic results in patients with pT2 Kidney tumors. Methodology: A comprehensive search of key databases was conducted up to December 2025, excluding conference abstracts and meta-analyses. Outcomes were assessed using odds ratios (OR), weighted mean differences (WMD), and standardized mean differences (SMD). Statistical analyses were performed using Review Manager software. The study protocol was registered on PROSPERO (CRD420251272895). Results: A pooled analysis of seven studies involving 2,715 patients showed that partial nephrectomy (PN) could reduce the probability of tumor recurrence (odds ratio [OR]: 0.57; 95% confidence interval [CI]: 0.39–0.84; P = 0.05). No significant statistical differences were observed in the four perioperative indicators—operative time, intraoperative estimated blood loss, length of hospital stay, and postoperative complications—between PN and radical nephrectomy (RN). In terms of prognosis, no significant difference was found between PN and RN in 2‑year or 5‑year cancer‑specific survival rates. Except for tumor size, baseline characteristics were comparable; the tumor size in the PN group was significantly smaller, which may be attributable to surgical decisions made out of concern for patient safety. Conclusion: PN may be prioritized for T2 renal tumors due to its advantages in reducing blood loss and hospitalization. However, high heterogeneity in perioperative outcomes warrants cautious interpretation. Future studies should control for tumor size disparities and compare long-term survival and subcategories of surgical approaches.

Indexed as

Kidney NeoplasmsNephrectomyNephronsOrgan Sparing TreatmentsHumansLength of StayNeoplasm Recurrence, LocalNeoplasm StagingOperative TimePrognosisTreatment Outcomekidney neoplasmspartical nephrectomyradical nephrectomyrenal tumorT2 stage

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.